FERRARI, Anna
 Distribuzione geografica
Continente #
EU - Europa 25.448
NA - Nord America 22.529
AS - Asia 7.824
SA - Sud America 1.497
AF - Africa 175
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 31
Totale 57.547
Nazione #
US - Stati Uniti d'America 22.208
IT - Italia 15.832
GB - Regno Unito 3.884
CN - Cina 2.819
SG - Singapore 2.137
BR - Brasile 1.187
NL - Olanda 1.166
HK - Hong Kong 1.107
SE - Svezia 879
DE - Germania 806
UA - Ucraina 633
FR - Francia 489
VN - Vietnam 475
RU - Federazione Russa 427
FI - Finlandia 374
TR - Turchia 359
KR - Corea 264
BG - Bulgaria 226
CH - Svizzera 210
CA - Canada 164
ID - Indonesia 115
IN - India 115
MX - Messico 100
AR - Argentina 96
IE - Irlanda 80
ES - Italia 78
JP - Giappone 57
EC - Ecuador 56
IR - Iran 54
ZA - Sudafrica 49
BE - Belgio 44
CZ - Repubblica Ceca 42
PL - Polonia 42
BD - Bangladesh 41
CO - Colombia 41
AU - Australia 39
CL - Cile 36
EG - Egitto 33
IQ - Iraq 32
PE - Perù 31
GR - Grecia 29
PK - Pakistan 25
TW - Taiwan 25
EU - Europa 24
MA - Marocco 24
PY - Paraguay 22
MY - Malesia 21
AT - Austria 19
DK - Danimarca 19
RO - Romania 19
SK - Slovacchia (Repubblica Slovacca) 19
AE - Emirati Arabi Uniti 18
SA - Arabia Saudita 18
UZ - Uzbekistan 18
HU - Ungheria 17
LT - Lituania 17
PH - Filippine 17
CR - Costa Rica 16
PT - Portogallo 16
DO - Repubblica Dominicana 15
KE - Kenya 15
RS - Serbia 15
TH - Thailandia 14
IL - Israele 13
TN - Tunisia 13
VE - Venezuela 13
NO - Norvegia 12
DZ - Algeria 11
NG - Nigeria 10
BO - Bolivia 9
AL - Albania 8
MN - Mongolia 8
NP - Nepal 8
AZ - Azerbaigian 7
JO - Giordania 7
LU - Lussemburgo 7
BY - Bielorussia 6
JM - Giamaica 6
KZ - Kazakistan 6
PA - Panama 6
SI - Slovenia 6
YE - Yemen 6
EE - Estonia 5
HR - Croazia 5
KG - Kirghizistan 5
SN - Senegal 5
UY - Uruguay 5
BH - Bahrain 4
HN - Honduras 4
LV - Lettonia 4
MK - Macedonia 4
MT - Malta 4
NZ - Nuova Zelanda 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BZ - Belize 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
Totale 57.502
Città #
Southend 2.835
Santa Clara 1.913
Fairfield 1.875
Milan 1.790
Ashburn 1.673
Woodbridge 1.381
Singapore 1.286
Jacksonville 1.282
Chandler 1.146
Hong Kong 1.100
Houston 955
Hefei 869
Wilmington 732
Ann Arbor 727
Dearborn 708
Seattle 700
Rome 689
Chicago 661
Cambridge 645
Jersey City 587
Beijing 576
London 495
Nyköping 476
Los Angeles 456
Turin 455
Salt Lake City 275
Princeton 255
Modena 237
Florence 223
Genoa 223
Sofia 218
Eugene 206
Seoul 202
Brescia 201
Izmir 199
Ho Chi Minh City 179
San Diego 173
Helsinki 166
Bologna 159
Moscow 149
The Dalles 146
Redwood City 144
Dallas 140
New York 139
Elk Grove Village 138
Tampa 121
Buffalo 111
Naples 111
Council Bluffs 109
Verona 104
Bergamo 100
São Paulo 97
Hanoi 96
Shanghai 86
Monza 84
Sterling 80
Trenton 80
Falls Church 77
Jakarta 76
Dublin 73
Des Moines 72
Padova 71
Parma 69
Frankfurt am Main 68
Perugia 65
Lancaster 64
Columbus 60
Pescara 59
Boardman 56
Norwalk 56
Palermo 55
Catania 50
Miami 50
Munich 48
Guangzhou 47
Nanjing 46
Fremont 45
Venice 45
Bari 43
Trieste 43
Brooklyn 42
Bremen 41
Dulles 41
Detroit 37
Reggio Emilia 37
Torino 37
Ancona 36
Kunming 36
Rio de Janeiro 36
Paris 35
Toronto 35
Ottawa 34
Tokyo 34
Phoenix 33
Pittsburgh 33
Trento 33
Tulare 33
Busto Arsizio 32
Lucca 32
Bellevue 31
Totale 33.009
Nome #
Monitoraggio dei pazienti con uso/abuso alcolico mediante la determinazione dell'Etil glucuronide (EtG) nel capello 9.857
Krokodil: The drug that kills 5.046
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 1.827
Atogepant: an emerging treatment for migraine 877
Allopregnanolone serum levels in female migraineurs 728
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors 684
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 625
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 458
Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients 448
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 437
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 418
Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study 411
Effective prophylactic treatments of migraine lower plasma glutamate levels 400
Past, present, and future prospects of medication-overuse headache classification 383
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 380
Clinical pharmacology of topiramate in migraine prevention 376
Methadone - metabolism, pharmacokinetics and interactions 375
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients 372
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 369
How children and parents evaluate the headache centre's intervention 365
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS 365
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 358
Monitoring of adherence to headache treatments by means of hair analysis 356
Effect of sumatriptan in different models of pain in rats 355
Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ) 351
Similarities and differences between chronic migraine and episodic migraine 351
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments 346
Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments 345
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 338
Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy 333
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 330
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 328
Headache: one of the most common and troublesome adverse reactions to drugs. 323
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone 319
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 314
Adverse reactions related to drugs for headache treatment: clinical impact 310
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 304
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 298
Paracetamol: new vistas of an old drug 297
Sucrose intake: Increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73 281
Farmacologia e Tossicologia 278
Analgesic drug taking: Beliefs and behavior among headache patients 272
Basal cutaneous pain threshold in headache patients 271
Paracetamol revisited 255
Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage 245
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 244
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 244
Focus on headache as an adverse reaction to drugs 241
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report 240
Polypharmacy Among Headache Patients: A Cross-Sectional Study 238
Le neuropatie da farmaci 237
Abuse of tramadol in a binge pattern in a young woman 236
Pharmacokinetics of indomethacin in chronic migraine patients after withdrawal from the overused combination of indomethacin, Prochlorperazine and caffeine 235
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. 235
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 227
Glutamate receptor antagonists with the potential for migraine treatment 224
Italian guidelines for primary headaches: 2012 revised version. 223
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 221
Analgesic abuse in chronic headache sufferers 220
Emerging problems in the pharmacology of migraine: interactions between triptans and drugs for prophylaxis 218
Zopiclone and prazepam dependance: role of hair analysis for the monitoring of treatment in a migraine patient 216
Pharmacoepidemiology of triptans in a headache centre 216
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 214
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 210
Abuso di sostanze psicoattive e sistema neuroendocrino dell’adolescente 209
Proteomic serum profile in menstrual-related and post menopause migraine 207
Trattamento farmacologico del dolore postoperatorio 206
Tramadol Abuse in a Binge Pattern in a Young Depressed Woman 205
Plasma glutathione level in chronic headache drug abuser patients 204
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 203
Clinical considerations preliminary to application of the Italian Society for the Study of Headache’s guidelines regarding migraine prophylactic treatment 203
Hair testing as a marker of adherence to headache treatments 203
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 200
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 200
Adolescenza, sostanze stupefacenti, riti di passaggio 199
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 197
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 196
Trattamento farmacologico integrato per la terapia delle tossicodipendenze 194
Hypertension and migraine comorbidity: Prevalence and risk of cerebrovascular events: Evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study) 192
Different effect of sumatriptan in models of thermal, chemical or cephalalgic pain, in rats 189
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 188
Activity of cromolyn sodium in dietary migraine: a double-blind placebo controlled multicenter trial 187
Azioni, interazioni, controindicazioni, tossicità dei farmaci utilizzati nella terapia dell'emicrania 187
Zopiclone and prazepam abuse in a chronic migraine patient 187
Accanimento terapeutico o riduzione del danno 187
Assessment of the efficacy and tolerability of triptans in clinical practice 186
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients 185
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 182
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 181
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 180
Storia della Sindrome di Neri Barrè 180
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 180
Chronic treatment with naltrexone and hepatic functions in heroin addicts 173
Evalutation of proteomic profile in menstrually-related migraine 169
Folate, vitamin B12, and serum homocysteine levels in patients with chronic migraine and medication-overuse headache 168
Attualità e prospettive dei trattamenti farmacologici 168
Evaluation of proteomic profile in menstrual-related migraine 168
Psycological profiles in tobacco and drug abusers 167
INFLUENCE OF FLUNARIZINE ON THE ALTERED ELECTRONYSTAGMOGRAPHIC (ENG) RECORDINGS IN MIGRAINE 167
Headache as an Adverse Reaction to Medication 165
Totale 43.860
Categoria #
all - tutte 175.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.047 0 0 0 0 0 297 435 716 225 673 448 253
2021/20224.493 169 519 430 465 191 223 256 296 449 315 568 612
2022/20235.226 494 438 281 409 526 604 248 531 682 252 426 335
2023/20246.492 276 362 371 578 746 468 719 722 389 501 685 675
2024/202512.633 679 491 494 937 1.951 1.498 1.029 909 1.428 869 1.196 1.152
2025/202611.590 1.890 1.183 1.817 2.773 3.635 292 0 0 0 0 0 0
Totale 57.810